Drug Type Growth factors |
Synonyms FGF-2 |
Target |
Mechanism FGFR1 stimulants(Fibroblast growth factor receptor 1 stimulants), FGFR2 stimulants(Fibroblast growth factor receptor 2 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tympanic Membrane Perforation | Phase 2 | US | 31 Oct 2016 | |
Furcation Defects | Phase 1 | IN | 01 May 2019 | |
Gingival Recession | Phase 1 | IN | 01 May 2019 | |
Periodontitis | Phase 1 | IN | 01 May 2019 |
Phase 2 | 57 | (FGF-2) | qzzkfkutvt(dtbsydnpmb) = annheijxau nkqwungccg (zaqhilcccq, nxjnweblbx - uhwcmqwpsh) View more | - | 11 Jun 2020 | ||
Placebo (Placebo) | qzzkfkutvt(dtbsydnpmb) = zstvyvubou nkqwungccg (zaqhilcccq, ukfgksqpxg - asqrvauiht) View more | ||||||
Not Applicable | - | - | TGFβ1 | pablbkilel(rvsrjqwfqt) = aghucsmcys zhrkmaepmv (regpdicdjl ) View more | - | 01 Mar 2012 | |
pablbkilel(rvsrjqwfqt) = txnggnswhx zhrkmaepmv (regpdicdjl ) View more |